Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
J-SHIFT: Ivabradine vs placebo in Japanese patients with chronic heart failure
jRCT2080222955Phase 3Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic heart failure (CHF) and heart failure with reduced ejection fraction (HFrEF) comparing Ivabradine arm with Placebo arm (2 arms). Started Sep 2015; status: completed.
02
Drugs
ivabradine
03
Conditions
chronic heart failure (CHF)heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on jRCT2080222955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222955.